Following the overwhelming positive response at DIA conference in Chicago, combined with preDIA event on Sunday evening, Data MATRIX is experiencing first hand some of the merger acquisition activity within biotech industry on the floor of the conference. Since 2002, Data MATRIX (DM) and its' sister company OCT have been privately held with zero debt.
DM delivers leading edge statistical analysis and data management services to biotechnology pharmaceutical, as well as CRO partners. DM is committed to providing the experienced teams that share clients’ passion in projects, with biostatistics and clinical data management expertise as the foundation. DM also provides scalable full service clinical trial solutions through the diverse and complementary strategic partner OCT.
Find DATA MATRIX at the booth #1249 next DIA conference in Boston!
For more information, please visit www.dm-matrix.com or contact Brian Langin directly at 508-769-9972, [email protected]
Â